Total Payments
$111,197
2024 Payments
$741.59
Companies
39
Transactions
801
Medicare Patients
4,330
Medicare Billing
$337,885
Payment Breakdown by Category
Other$96,098 (86.4%)
Food & Beverage$11,862 (10.7%)
Travel$2,969 (2.7%)
Consulting$250.00 (0.2%)
Education$18.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96,098 | 39 | 86.4% |
| Food and Beverage | $11,862 | 725 | 10.7% |
| Travel and Lodging | $2,969 | 33 | 2.7% |
| Consulting Fee | $250.00 | 1 | 0.2% |
| Education | $18.77 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $99,736 | 180 | $0 (2024) |
| PFIZER INC. | $2,513 | 98 | $0 (2024) |
| Boston Scientific Corporation | $1,822 | 107 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,374 | 85 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $1,090 | 76 | $0 (2023) |
| Amgen Inc. | $834.21 | 46 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $600.10 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $463.39 | 33 | $0 (2023) |
| Amarin Pharma Inc. | $321.15 | 21 | $0 (2022) |
| Gilead Sciences, Inc. | $280.60 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $741.59 | 33 | Boston Scientific Corporation ($402.83) |
| 2023 | $1,407 | 83 | Boston Scientific Corporation ($471.26) |
| 2022 | $1,919 | 118 | Boston Scientific Corporation ($460.65) |
| 2021 | $1,766 | 112 | Janssen Pharmaceuticals, Inc ($350.68) |
| 2020 | $672.83 | 39 | Janssen Pharmaceuticals, Inc ($153.43) |
| 2019 | $1,700 | 125 | PFIZER INC. ($317.98) |
| 2018 | $11,513 | 115 | Novartis Pharmaceuticals Corporation ($10,130) |
| 2017 | $91,479 | 176 | Novartis Pharmaceuticals Corporation ($88,854) |
All Payment Transactions
801 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.80 | General |
| 11/14/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $39.56 | General |
| Category: Medical Device | ||||||
| 11/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/25/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Pacemakers | ||||||
| 10/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.92 | General |
| 10/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: Medical Device | ||||||
| 08/20/2024 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: WATCHMAN Pro_IC | ||||||
| 08/06/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/29/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $22.38 | General |
| 05/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: DIABETES | ||||||
| 05/13/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/07/2024 | Boston Scientific Corporation | VersaCross Steerable Access Solution (Device) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: VersaCross Steerable Access Solution_ICG | ||||||
| 04/23/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/16/2024 | Boston Scientific Corporation | VersaCross Access Solution (Device) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: VersaCross Access Solution_ICG | ||||||
| 04/08/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.64 | General |
| 04/01/2024 | Boston Scientific Corporation | VersaCross Access Solution (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: VersaCross Access Solution_ICG | ||||||
| 03/26/2024 | Boston Scientific Corporation | VersaCross Access Solution (Device) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: VersaCross Access Solution_ICG | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 999 | 1,182 | $244,029 | $86,332 |
| 2022 | 19 | 1,123 | 1,482 | $252,229 | $87,357 |
| 2021 | 22 | 1,153 | 1,543 | $256,668 | $86,689 |
| 2020 | 19 | 1,055 | 1,450 | $227,010 | $77,507 |
Total Patients
4,330
Total Services
5,657
Medicare Billing
$337,885
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 379 | $76,179 | $31,187 | 40.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 112 | 113 | $43,505 | $14,800 | 34.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 216 | 221 | $44,200 | $11,487 | 26.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 78 | 109 | $21,473 | $9,880 | 46.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 72 | $22,464 | $7,264 | 32.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 90 | $12,420 | $5,369 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 22 | 22 | $5,522 | $2,170 | 39.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 27 | 27 | $7,790 | $1,684 | 21.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 18 | 18 | $5,886 | $1,485 | 25.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 17 | 18 | $1,458 | $347.04 | 23.8% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 16 | 16 | $1,072 | $236.86 | 22.1% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 36 | 36 | $864.00 | $199.44 | 23.1% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 16 | 16 | $656.00 | $116.87 | 17.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 45 | 45 | $540.00 | $107.55 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 391 | $78,591 | $30,775 | 39.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 226 | 232 | $46,400 | $12,000 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 79 | 152 | $29,944 | $11,946 | 39.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 73 | 74 | $28,490 | $11,305 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $21,528 | $8,007 | 37.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 14 | 15 | $14,355 | $3,366 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 26 | 26 | $6,526 | $2,642 | 40.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 45 | $6,210 | $2,481 | 40.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2022 | 22 | 22 | $5,984 | $1,384 | 23.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 120 | 132 | $3,564 | $846.38 | 23.7% |
| 85610 | Blood test, clotting time | Office | 2022 | 15 | 129 | $2,193 | $547.18 | 25.0% |
About Dr. James Zebrack, MD
Dr. James Zebrack, MD is a Cardiovascular Disease healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003808940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Zebrack, MD has received a total of $111,197 in payments from pharmaceutical and medical device companies, with $741.59 received in 2024. These payments were reported across 801 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($96,098).
As a Medicare-enrolled provider, Zebrack has provided services to 4,330 Medicare beneficiaries, totaling 5,657 services with total Medicare billing of $337,885. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Salt Lake City, UT
- Active Since 08/17/2005
- Last Updated 01/27/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1003808940
Products in Payments
- ENTRESTO (Drug) $99,574
- ELIQUIS (Drug) $3,020
- XARELTO (Drug) $1,374
- WATCHMAN Access System (Device) $773.75
- Repatha (Biological) $726.56
- JARDIANCE (Drug) $578.78
- WATCHMAN (Device) $508.82
- BRILINTA (Drug) $467.12
- WATCHMAN FLX (Device) $352.48
- Vascepa (Drug) $321.15
- CAMZYOS (Drug) $243.27
- LifeVest (Device) $238.32
- VYNDAQEL (Drug) $197.42
- LEQVIO (Drug) $161.42
- KENGREAL (Drug) $149.27
- PRALUENT ALIROCUMAB INJECTION (Biological) $137.23
- (5044) MCOT (Device) $135.03
- VERQUVO (Drug) $134.09
- OPSUMIT (Drug) $109.27
- Corlanor (Drug) $107.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Salt Lake City
Dr. John Ryan, Mbbchbao, MBBCHBAO
Cardiovascular Disease — Payments: $1.1M
Cardiovascular Disease $1.1M
Robert Fowles, M.d, M.D
Cardiovascular Disease — Payments: $630,538
Cardiovascular Disease $630,538
John Day, Md, MD
Cardiovascular Disease — Payments: $430,463
Cardiovascular Disease $430,463
Roger Freedman, Md, MD
Cardiovascular Disease — Payments: $260,682
Cardiovascular Disease $260,682
Josef Stehlik, Md, MD
Cardiovascular Disease — Payments: $169,217
Cardiovascular Disease $169,217
James Fang
Cardiovascular Disease — Payments: $161,617
Cardiovascular Disease $161,617